These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8163715)

  • 1. Bolus infusion of famotidine: effects on gastric pH by repeated 12-hour doses of 20 mg in postoperative patients.
    Savarino V; Mela GS; Zentilin P; Larghero G; Cutela P; Mele MR; Vassallo A; Mansi C; Dallorto E; Celle G
    J Clin Pharmacol; 1994 Feb; 34(2):148-52. PubMed ID: 8163715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
    Hogan DL; McQuaid KR; Koss MA; Crombie DL; Hunter S; Metz C; Euler AR; Isenberg JI
    Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidine.
    Amsden GW; Goss TF; Harrison NJ; D'Andrea DT; Schentag JJ
    J Clin Pharmacol; 1994 Dec; 34(12):1191-8. PubMed ID: 7738215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effect of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: results of a prospective, randomized, crossover study.
    Baghaie AA; Mojtahedzadeh M; Levine RL; Fromm RE; Guntupalli KK; Opekun AR
    Crit Care Med; 1995 Apr; 23(4):687-91. PubMed ID: 7712759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of 24-hour gastric pH measurements in trauma patients receiving intravenous famotidine by intermittent bolus versus continuous infusion administration.
    Jones LA; Gonzalez ER; Reines HD; Venitz J
    Ann Pharmacother; 1994; 28(7-8):841-4. PubMed ID: 7949496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of an intravenous bolus of famotidine and Mylanta II for the control of gastric pH in critically ill patients.
    Wilson P; Clark GW; Anselmino M; Welch NT; Singh S; Perdikis G; Hinder RA
    Am J Surg; 1993 Dec; 166(6):621-4; discussion 624-5. PubMed ID: 8273840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
    Bachmann K; Sullivan TJ; Jauregui L
    J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The action of 10 mg famotidine versus 200 mg cimetidine: onset and magnitude of antisecretory action within the first 2 hours after administration.
    Decktor D; Houle JM; Pierce CH
    Am J Ther; 1998 Mar; 5(2):97-100. PubMed ID: 10099044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of gastric acid secretion by intravenous administration of famotidine in children.
    Treem WR; Davis PM; Hyams JS
    J Pediatr; 1991 May; 118(5):812-6. PubMed ID: 2019939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of intermittent and continuous intravenous infusion of famotidine on gastric acidity in patients with peptic ulcers.
    Watanabe Y; Tsumura H; Sasaki H; Morimoto T
    Clin Ther; 1990; 12(6):534-46. PubMed ID: 2289221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of gastric pH above 6 with intravenous famotidine in patients with a bleeding duodenal ulcer.
    Delchier JC; el Amine I; Roudot-Thoraval F; Elouaer-Blanc L; Lamarque D; Stanescu L
    Aliment Pharmacol Ther; 1995 Apr; 9(2):191-6. PubMed ID: 7605861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identical 24-hour intragastric pH response to low continuous infusion doses of famotidine in active gastric ulcer patients.
    Espitia VR; Yamaoka K; Tanaka J; Kisu T
    Intern Med; 1992 Mar; 31(3):299-303. PubMed ID: 1611178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
    Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
    J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of gastric pH control with intermittent and continuous intravenous infusion of famotidine in ICU patients.
    Heiselman DE; Hulisz DT; Fricker R; Bredle DL; Black LD
    Am J Gastroenterol; 1995 Feb; 90(2):277-9. PubMed ID: 7847300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
    Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
    J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists.
    Katsu K; Yabe S
    Clin Ther; 1995; 17(3):433-10. PubMed ID: 7585847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
    Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G
    Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V
    Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of intragastric pH > 4 with famotidine in duodenal ulcer patients: factors influencing drug requirements.
    Delchier JC; Roudot-Thoraval F; Stanescu L; Deharvengt MC; Elouaer Blanc L
    Gut; 1994 Jun; 35(6):750-4. PubMed ID: 8020798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.